🏢 公司NewsroomJBSCodex · 实盘可交易 · 做多市场:美股▼ 亏 -0.49% · 已结算把握 5/10
北京时间·🕒 发布 19:36:37(美东 07:36)·⟳ 抓取 19:36:43 +6s·⚡ 决策 08-07 19:46:29 +9m46s·80.8 天前
印尼主权基金将向JBS澳新业务合资平台投资25亿美元
Danantara以25亿美元取得JBS澳大利亚和新西兰业务25%股权，隐含澳新平台约100亿美元估值，并新增最多25亿美元投资能力，直接验证区域资产价值。
📄 原文JBS↗ 原文
Indonesia Sovereign Fund Invests USD$2.5 Billion in Joint Venture with JBS
Danantara will acquire a 25% stake in JBS’s Australia and New Zealand operations. The partnership aims to invest up to…
▼ 亏 -0.49%入场 08-07 盘前首笔 @14.05 → 离场 08-10 常规开盘 @14.00
日 K 取自复盘打分切片 · 蓝点/蓝虚线 = 纸面入场价 · 灰虚线 = 纸面离场 · 持有期红底 = 赚(价格在入场线上方)、绿底 = 亏
💡 交易逻辑主权基金入股澳新平台，资产重估小仓
怎么买 限价买入 不高于昨收 +2%、仅下一个交易日，不成交作废
怎么卖 止盈 +4%(半仓)/+7%(清仓) · 止损 -3.5% · 时间止损 4日
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
分时走势
做多 JBS.US JBS
建仓日早于近 30 天,只有日线图
成交明细 · 纸面
做多 JBS.US JBS
| 收益状态 | -0.49% 已平仓 |
|---|---|
| 进场成交 | 2026-08-07 · 盘前首笔 · 08-07 19:56 北京 · @14.0489 |
| 离场成交 | 2026-08-10 · 常规开盘 · @13.9974 |
| 毛收益 | -0.37% |
| 成本 | +0.12% |
| 净收益 | -0.49% |
| 计入收益 | -0.49% |
| 建仓日 | 2026-08-07 · 进场不早于新闻时刻 + 2 分钟 |
收益口径 event_time_plus_2min_10min_walk_open_topup_to_next_open_exchange_calendar_fill_model_local_notional_v9 · method_id m8db1cbc8f2d · 截至 2026-10-27 15:33
研究档案
消息传播链
- JBS官网盘前发布新闻稿，说明Danantara将取得澳新业务25%权益并提供最高50亿美元区域投资资本。市场反应:美股仍处盘前不可连续成交，JBS.US上一常规收盘价13.685美元。
- KB命中JBS N.V.同日6-K，披露Danantara合作与25亿美元投资事项，构成交易所层面的一手确认。
关键理由
- Danantara以25亿美元取得JBS澳大利亚和新西兰业务25%股权，隐含澳新平台约100亿美元估值，并新增最多25亿美元投资能力，直接验证区域资产价值。
- KB研报显示JBS Australia 1Q26收入约21亿美元、EBITDA约1.52亿美元，本次25亿美元入资约相当于其季度收入1.2倍，量级足以支撑短线资产重估预期。
- 公司官网与SEC 6-K同日确认，系统0分钟抓取且近72小时未命中重复；但先例深研显示高相似样本不足，仓位由small降为probe。
主要风险
- 交易仍需澳大利亚监管批准，且资金主要进入合资平台用于扩张，不等同于母公司即时可分配现金。
- 历史先例多来自EV/高现金消耗公司战略投资，和成熟肉类资产少数股权交易相似度不足，涨幅口径存疑且需防高开低走。
反向证据
- 做多前查反向 · 来源 kb_search · 日期 2026-05-18 · 影响 weakens
近期研报称JBS 1Q26美国/澳大利亚牛肉和PPC表现偏弱，澳洲牛周期可能见顶并压制后续利润率。
检索:JBS.US recent risks leverage regulatory approval Australia Danantara transaction antitrust cattle cycle margins 原文 ↗ - 做多前查反向 · 来源 kb_search · 日期 2026-08-07 · 影响 weakens
KB命中SEC 6-K确认交易，但公告同时写明需澳大利亚监管批准和惯常交割条件。
检索:JBS Danantara USD 2.5 billion joint venture Australia New Zealand 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例没有推翻做多方向，但显著压仓位、收紧买点，并把止盈从5%-10%下调到4%-7%。
方向:可比样本方向偏正但分化很大，资金/战略背书型事件胜率取决于是否被解读为资产重估而非稀释融资。
涨幅量级:event_study的decision_grade为0；aligned_first_print虽显示3日中位约+15%，但样本主要是高beta EV，不能直接用于JBS，只保守取4%-7%止盈。
形态:RIVN、JOBY、9863.HK均出现开盘跳空后盘中或次日回落，提示这类公告容易高开派发。
历史先例(按相似度)
- 相似度 6/10 RIVN.US 2024-06-25 大众先投10亿美元、拟与Rivian成立50/50软件架构JV，总投资最高50亿美元。 原文 ↗
事件后 +1日 +23.2% · +2日 +21.0% · +3日 +12.2% · +4日 +16.4% · +5日 +24.5%
⚠来源层级不符(声明issuer/实为media)·相位不对齐(post!=target_pre) — 该行涨幅别用来定止盈止损
相似度依据:同为美股盘前/盘后大额战略投资和JV扩张，但Rivian是高现金消耗EV公司，行业和估值弹性明显不同。
经验:大额外部战略资金能快速触发重估，但次日高开后回落明显，追开盘价需要收紧仓位。 - 相似度 6/10 XPEV.US 2023-07-26 大众以约7亿美元认购小鹏约4.99%股份并达成技术合作。 原文 ↗
事件后 +1日 +26.7% · +2日 +31.6% · +3日 +52.3% · +4日 +36.2% · +5日 +30.5%
相似度依据:同为美股可交易标的获外部战略方入股并绑定合作，但小鹏的技术授权和车型合作弹性强于JBS区域资产入股。
经验:战略方带来分发和技术背书时反应可延续数日，但这是成长股高beta样本，不宜直接外推到JBS。 - 相似度 5/10 NIO.US 2023-06-20 CYVN向蔚来投入7.385亿美元并获约7%权益和董事提名权。 原文 ↗
事件后 +1日 -0.5% · +2日 -3.5% · +3日 -5.1% · +4日 -10.3% · +5日 -10.6%
相似度依据:同为中东资金战略入股美股ADR，但蔚来是融资补血逻辑，且公告前已明显反弹。
经验:资金入股若被市场解读为补流动性而非资产重估，短线可能不涨反跌。 - 相似度 5/10 NIO.US 2023-12-18 CYVN追加22亿美元认购蔚来新股，完成后持股约20.1%。 原文 ↗
事件后 +1日 +4.6% · +2日 +10.5% · +3日 -0.8% · +4日 +3.9% · +5日 +5.5%
⚠锚前1-2日已异动7.4%>锚定日4.6% — 该行涨幅别用来定止盈止损
相似度依据:同为主权背景资金追加大额入股，但锚前已有异动且仍属于亏损车企融资。
经验:追加投资可给首日支撑，但若锚前已反应，3日收益容易归零。 - 相似度 5/10 JOBY.US 2024-10-02 丰田追加5亿美元投资Joby，支持认证和商业化生产。 原文 ↗
事件后 +1日 +27.9% · +2日 +16.9% · +3日 +24.0% · +4日 +24.6% · +5日 +18.1%
相似度依据:同为战略股东追加大额资金，但Joby处于认证商业化前阶段，对资金缺口更敏感。
经验:外部产业资本背书对小市值成长股弹性很大，但不适合给成熟周期公司定止盈上限。 - 相似度 5/10 9863.HK 2023-10-26 Stellantis拟15亿欧元入股零跑约20%，并设Leapmotor International全球JV。 原文 ↗
事件后 +1日 -10.9% · +2日 -12.6% · +3日 -12.5% · +4日 -26.4% · +5日 -24.3%
相似度依据:同为战略入股加国际JV，但港股机制、EV行业和此前股价预期差都不同。
经验:战略入股若公告当天高开过猛，可能直接变成派发行情，不能用市价追。 - 相似度 4/10 LCID.US 2024-03-25 Lucid获PIF关联方10亿美元可转优先股私募。 原文 ↗
事件后 +1日 +5.4% · +2日 -0.4% · +3日 +7.2% · +4日 +2.9% · +5日 +3.2%
相似度依据:同为主权基金关联方资金注入，但Lucid是融资续命和稀释交易，机制弱于JBS的资产估值验证。
经验:主权资金本身不是充分利好，若市场更关注稀释或烧钱，涨幅会快速收窄。 - 相似度 4/10 AML.L 2022-07-15 Aston Martin宣布PIF战略投资并进行6.53亿英镑股权融资，PIF成第二大股东。 原文 ↗
AML.L首反应日+23.7%、3日+39.8%、5日+42.6%。
⚠来源层级不符(声明primary_disclosure/实为media) — 该行涨幅别用来定止盈止损
相似度依据:同为PIF战略入股，但同时伴随大额配股和供股，融资稀释与JBS不同。
经验:陷入困境的公司获主权资金可能短线暴涨，但波动来自再融资重置，不适合作JBS涨幅锚。 - 相似度 3/10 LCID.US 2022-11-08 Lucid宣布6亿美元ATM和PIF关联方最高9.15亿美元额外私募。 原文 ↗
事件后 +1日 -17.0% · +2日 -10.3% · +3日 -4.4% · +4日 -9.6% · +5日 -8.4%
⚠相位不对齐(post!=target_pre) — 该行涨幅别用来定止盈止损
相似度依据:同为主权背景资金支持，但伴随ATM和稀释融资，和JBS少数股权变现差异较大。
经验:大额融资若稀释属性更强，战略背书无法阻止首日下跌。
工具调用 · 历史记录,结果未知(8 种)
- search_processed_events · 结果未知
- normalize_ticker · 结果未知
- stock_quote · 结果未知
- kb_search · 结果未知
- search_case_library · 结果未知
- validate_order · 结果未知
- list_mcp_resources · 结果未知
- event_study · 结果未知
原文全文
展开原文 · 4,168 字
Danantara will acquire a 25% stake in JBS’s Australia and New Zealand operations. The partnership aims to invest up to USD$5 billion across Indonesia, Australia, New Zealand and other Southeast Asian markets
JBS has formed a strategic partnership with Danantara Investment Management, the investment arm of Indonesia’s sovereign wealth fund, and intends to expand its presence across Indonesia, Australia, New Zealand and other Southeast Asian markets. The transaction includes a USD$2.5 billion equity investment by Danantara for a 25% stake in JBS’s Australia and New Zealand operations.
In addition to the equity contribution, the joint venture is expected to provide incremental investment capacity of USD$2.5 billion, bringing total available capital to up to USD$5 billion to fund acquisitions, greenfield investments and other growth opportunities across Indonesia, Australia, New Zealand and Southeast Asia.
The region combines population scale, rising incomes, urbanization and increasing protein consumption. Official data from the ASEAN Secretariat show that the region reached approximately 745 million people in 2024. The initiative is designed to expand JBS’s investment capacity, accelerate regional growth and leverage its Australian operations as a platform to scale in markets considered strategic for global protein consumption. Australia remains a core pillar of JBS’s geographic diversification, with strong export positioning and a key role in balancing JBS’s global results.
“Our partnership with Danantara Indonesia marks an important step in our long-term growth strategy in Southeast Asia. As a cornerstone of the broader JBS global platform, our Australia and New Zealand footprint provides strong operations, world class standards, and significant growth potential. Together with Danantara, we are well positioned to expand our presence across Indonesia and Southeast Asia, strengthen regional protein supply chains, broaden market access, and accelerate the development of Indonesia’s protein sector,” said Gilberto Tomazoni, Global CEO of JBS.
According to Tomazoni, the move is aligned with JBS’s long-term strategy, focused on geographic diversification, branded and value-added products, sustainable growth and shareholder returns.
“This investment is a strong endorsement of JBS Australia’s proven track record in establishing and growing food businesses throughout Australia, New Zealand and around the world. Under the structure of the partnership, JBS Australia’s operations remain unchanged — existing management retains day-to-day control, and nothing changes for our 17,000 team members, customers and producer partners,” said Brent Eastwood, CEO of JBS Australia.
The transaction comes amid structural growth in global protein demand. Projections from the OECD and the Food and Agriculture Organization indicate that global meat consumption is expected to increase through 2034, with estimated growth of 21% for poultry, 16% for sheep meat, 13% for beef and 5% for pork. The report also highlights countries such as Indonesia, the Philippines and Vietnam among those expected to drive demand.
Indonesia is also a key market in the global halal food segment, which has become increasingly relevant for the protein industry. According to DinarStandard, the global halal food market was valued at approximately USD$1.43 trillion in 2023 and is projected to reach USD$1.94 trillion by 2028, driven by population growth and increasing demand for certified products.
“We are building a stronger platform to capture long-term growth in global protein consumption. At the same time, we are creating the conditions to expand our presence in Asia, one of the industry’s most dynamic regions,” said Tomazoni.
The transaction is subject to required Australian regulatory approvals and customary conditions for transactions of this nature.
Danantara is being advised by PwC, BCG, A&O Shearman and Barrenjoey. JBS is being advised by EY, De Brauw Blackstone Westbroek N.V. (the Netherlands) and MinterEllison (Australia).
The post Indonesia Sovereign Fund Invests USD$2.5 Billion in Joint Venture with JBS appeared first on JBS .
JBS has formed a strategic partnership with Danantara Investment Management, the investment arm of Indonesia’s sovereign wealth fund, and intends to expand its presence across Indonesia, Australia, New Zealand and other Southeast Asian markets. The transaction includes a USD$2.5 billion equity investment by Danantara for a 25% stake in JBS’s Australia and New Zealand operations.
In addition to the equity contribution, the joint venture is expected to provide incremental investment capacity of USD$2.5 billion, bringing total available capital to up to USD$5 billion to fund acquisitions, greenfield investments and other growth opportunities across Indonesia, Australia, New Zealand and Southeast Asia.
The region combines population scale, rising incomes, urbanization and increasing protein consumption. Official data from the ASEAN Secretariat show that the region reached approximately 745 million people in 2024. The initiative is designed to expand JBS’s investment capacity, accelerate regional growth and leverage its Australian operations as a platform to scale in markets considered strategic for global protein consumption. Australia remains a core pillar of JBS’s geographic diversification, with strong export positioning and a key role in balancing JBS’s global results.
“Our partnership with Danantara Indonesia marks an important step in our long-term growth strategy in Southeast Asia. As a cornerstone of the broader JBS global platform, our Australia and New Zealand footprint provides strong operations, world class standards, and significant growth potential. Together with Danantara, we are well positioned to expand our presence across Indonesia and Southeast Asia, strengthen regional protein supply chains, broaden market access, and accelerate the development of Indonesia’s protein sector,” said Gilberto Tomazoni, Global CEO of JBS.
According to Tomazoni, the move is aligned with JBS’s long-term strategy, focused on geographic diversification, branded and value-added products, sustainable growth and shareholder returns.
“This investment is a strong endorsement of JBS Australia’s proven track record in establishing and growing food businesses throughout Australia, New Zealand and around the world. Under the structure of the partnership, JBS Australia’s operations remain unchanged — existing management retains day-to-day control, and nothing changes for our 17,000 team members, customers and producer partners,” said Brent Eastwood, CEO of JBS Australia.
The transaction comes amid structural growth in global protein demand. Projections from the OECD and the Food and Agriculture Organization indicate that global meat consumption is expected to increase through 2034, with estimated growth of 21% for poultry, 16% for sheep meat, 13% for beef and 5% for pork. The report also highlights countries such as Indonesia, the Philippines and Vietnam among those expected to drive demand.
Indonesia is also a key market in the global halal food segment, which has become increasingly relevant for the protein industry. According to DinarStandard, the global halal food market was valued at approximately USD$1.43 trillion in 2023 and is projected to reach USD$1.94 trillion by 2028, driven by population growth and increasing demand for certified products.
“We are building a stronger platform to capture long-term growth in global protein consumption. At the same time, we are creating the conditions to expand our presence in Asia, one of the industry’s most dynamic regions,” said Tomazoni.
The transaction is subject to required Australian regulatory approvals and customary conditions for transactions of this nature.
Danantara is being advised by PwC, BCG, A&O Shearman and Barrenjoey. JBS is being advised by EY, De Brauw Blackstone Westbroek N.V. (the Netherlands) and MinterEllison (Australia).
The post Indonesia Sovereign Fund Invests USD$2.5 Billion in Joint Venture with JBS appeared first on JBS .
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。